Validation and Compliance

Feb 01, 2013
BioPharm International
Shortages spur efforts to overhaul manufacturing oversight.
Jan 01, 2013
BioPharm International
The EU fine-tunes the Falsified Medicines Directive.
Jan 01, 2013
BioPharm International
Shortages spur efforts to overhaul manufacturing oversight.
Dec 01, 2012
BioPharm International
White House and Congress likely to struggle over funding for bio/pharmaceutical regulation.
Nov 01, 2012
BioPharm International
Manufacturing and in-depth characterization provide basis for demonstrating product equivalence.
Oct 01, 2012
BioPharm International
User fees aim to speed approvals and support inspections.
Sep 05, 2012
By BioPharm International Editors
USP Hosts Symposium on Science and Standards
Sep 01, 2012
BioPharm International
Manufacturers and regulators struggle to control phony versions of crucial medicines.
Aug 01, 2012
BioPharm International
Import controls and risk strategies aim to promote quality and spur new drug development.
Jul 01, 2012
BioPharm International
Multiple initiatives are moving forward to maintain US leadership in biopharm R&D.
native1_300x100
lorem ipsum